Criterion • Guideline • Consensus
Guideline on the assessment and management of cardiovascular risk in China
The Joint Task Force for Guideline on the Assessment and Management of Cardiovascular Risk in China
Published 2019-01-06
Cite as Chin J Prev Med, 2019, 53(1): 13-35. DOI: 10.3760/cma.j.issn.0253-9624.2019.01.004
Abstract
Cardiovascular disease (CVD) is the leading cause of death and burden of diseases in China. Prevention and control of CVD has been challenging. Risk assessment and management for CVD risk factors are essential for primary prevention of CVD. According to recent observational and interventional evidences worldwide and studies in Chinese population, the guideline introduced how to conduct cardiovascular risk assessment in China, including the procedure for 10-year and lifetime risk assessment, the risk stratification, and the application of web-based and mobile risk assessment tools. Furthermore, in order to facilitate the primary prevention of CVD, the guideline targeted therapeutic lifestyle changes, and highlighted principles for management of blood pressure, lipids, and glucose, etc. The implementation of the guideline will facilitate the risk assessment of CVD and risk factor management, and promote both individualized and community-based prevention of CVD in China.
Key words:
Cardiovascular diseases; Risk assessment; Primary prevention; Guideline
Contributor Information
The Joint Task Force for Guideline on the Assessment and Management of Cardiovascular Risk in China